AstraZeneca inks U.S. co-commercialization deal for OIC med
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 11:14AM CDT
AZN: 69.91 (-0.25), NKTR: 11.22 (+0.04)
FDA clears Daiichi-Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 6:55PM CST
PTLA: 38.79 (+0.75), PFE: 35.44 (+0.41), BMY: 64.64 (+1.18), JNJ: 102.06 (+0.73), ISIS: 65.70 (+1.64), MDCO: 28.31 (+0.49), BAX: 70.57 (+0.42), AZN: 69.91 (-0.25), MRK: 57.25 (-0.18), SCLN: 9.00 (-0.04), MSLI: 2.60 (+0.05)
ArQule prostate cancer drug candidate successful in Phase 2
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:19AM CST
ARQL: 2.16 (unch)
Ad Comm approaches for Daiichi Sankyo anticoagulant
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 12:49PM CDT
The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 102.06 (+0.73), PTLA: 38.79 (+0.75), PFE: 35.44 (+0.41), BMY: 64.64 (+1.18), PRTA: 36.91 (+0.52), PBYI: 230.48 (+4.03)